Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Experimental Physiology 90.5 pp 755-761
DOI: 10.1113/expphysiol.2005.030908
© The Physiological Society 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/5/755    most recent
expphysiol.2005.030908v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burniston, J. G
Right arrow Articles by Goldspink, D. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burniston, J. G
Right arrow Articles by Goldspink, D. F
Related Collections
Right arrow Muscle

Angiotensin II induces apoptosis in vivo in skeletal, as well as cardiac, muscle of the rat

Jatin G Burniston1, Amarjit Saini1, Lip-Bun Tan2 and David F Goldspink1

1 Research Institute for Sport & Exercise Sciences, Liverpool John Moores University, Webster Street, Liverpool L3 2ET, UK 2 Academic Unit of Molecular Vascular Medicine, University of Leeds, Leeds General Infirmary, Leeds LS2 9JT, UK

Our previous work has established that angiotensin II is cardiotoxic. Here we sought to investigate whether skeletal muscle is similarly susceptible to damage. Male Wistar rats were either given a single subcutaneous injection of angiotensin II (range 1 µg kg–1 to 10 mg kg–1) or only the vehicle and killed 7 h later, or implanted with preconditioned osmotic pumps dispensing 1 mg kg–1 day–1 angiotensin II and killed 9 or 18 h later. Apoptotic (caspase 3 positive) myocytes were counted on cryosections of the heart, soleus, tibialis anterior and diaphragm muscle. Single injections of 100 µg kg–1 to 10 mg kg–1 angiotensin II induced significant (P < 0.05) myocyte apoptosis (per 104 viable myocytes) in the heart and this was heterogeneously distributed, peaking (5.7 ± 0.6; P < 0.05) at a point 6 mm from the apex, i.e. approximately three-quarters of the way towards the base. The slow-twitch soleus muscle was also damaged significantly (peak = 2.6 ± 0.4; P < 0.05), while only the administration of 1 mg kg–1 induced significant (P < 0.05) apoptosis in the fast-twitch tibialis anterior muscle (peak = 1.2 ± 0.3). Infusion of 1 mg kg–1 day–1 angiotensin II induced more myocyte apoptosis than a single bolus administration of the same dose, and in general there was a higher incidence of apoptosis in muscles harvested after 18 than after 9 h. Infusion of 1 mg kg–1 day–1 angiotensin II over 18 h induced significant (P < 0.05) myocyte apoptosis in the heart (3.3 ± 0.4), soleus (3.9 ± 1), tibialis anterior (5.9 ± 0.4) and diaphragm (19.8 ± 5.6) muscle. Depending on the muscle type, angiotensin II induces myocyte apoptosis in skeletal muscle to a similar or greater extent as in cardiac muscle, supporting the hypothesis that angiotensin II is generally toxic to all striated muscles.

(Received 14 May 2005; accepted after revision 28 June 2005; first published online 29 June 2005)
Corresponding author J. G. Burniston, Research Institute for Sports and Exercise Sciences, Liverpool John Moores University, Webster Street, Liverpool L3 2ET, UK. Email: j.burniston{at}livjm.ac.uk







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the The Physiological Society.